This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.
Company Filing History:
1 out of 834,453 Years Active: 2000
Title: Kathrine Meyer Siegler: Innovator in Cancer Diagnostics
Introduction
Kathrine Meyer Siegler is a notable inventor based in Largo, FL (US). She has made significant contributions to the field of cancer diagnostics, particularly in the area of adenocarcinoma. Her innovative work has the potential to improve the diagnosis and prognosis of this type of cancer.
Latest Patents
Kathrine holds 1 patent for her invention titled "Macrophage migration inhibitory factor as diagnostic and prognostic." This patent describes a method and a kit designed for the diagnosis and prognosis of human adenocarcinoma. The method and kit measure levels of macrophage migration inhibitory factor within tumor cells, providing valuable insights for medical professionals.
Career Highlights
Throughout her career, Kathrine has focused on advancing medical diagnostics. Her work has been instrumental in developing tools that aid in the early detection of cancer, which is crucial for effective treatment and patient outcomes.
Collaborations
Kathrine has collaborated with esteemed colleagues, including Perry B Hudson and Said I Hakky. These partnerships have enhanced her research and contributed to the success of her innovations.
Conclusion
Kathrine Meyer Siegler's contributions to cancer diagnostics exemplify the impact of innovative thinking in medicine. Her work continues to pave the way for advancements in the diagnosis and treatment of adenocarcinoma.